| Dr Michael Hale Vagts, MD | |
|
222 W 39th Ave, San Mateo, CA 94403-4364 | |
| (650) 573-2530 | |
| Not Available |
| Full Name | Dr Michael Hale Vagts |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 13 Years |
| Location | 222 W 39th Ave, San Mateo, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215223193 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| County Of San Mateo | 9032023171 | 242 |
News Archive
Sales increased by 14 percent during the fourth quarter and amounted to SEK 67 (59) million. Calculated in local currency growth was 15 percent. Sales for the year amounted to SEK 275 (225) million, corresponding to an increase of 22 percent. Calculated in local currencies growth was 10 percent.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Contamination of urine samples from infants and the elderly is so common that physicians often needlessly prescribe broad-spectrum antibiotics prophylactically. Now, a team at The Hebrew University of Jerusalem's BioDesign: Medical Innovation program has developed an innovative microfiber pad that can save time and money in the collection of sterile samples.
The Plasma Protein Therapeutics Association (PPTA) applauds the introduction of bipartisan legislation, the Preserving Access to Orphan Drugs Act (H.R. 2672) and (S. 1423), which will safeguard the development of drugs and therapies that treat patients with rare diseases by eliminating barriers to innovation.
› Verified 6 days ago
| Entity Name | County Of San Mateo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679642326 PECOS PAC ID: 9032023171 Enrollment ID: O20031126000292 |
News Archive
Sales increased by 14 percent during the fourth quarter and amounted to SEK 67 (59) million. Calculated in local currency growth was 15 percent. Sales for the year amounted to SEK 275 (225) million, corresponding to an increase of 22 percent. Calculated in local currencies growth was 10 percent.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Contamination of urine samples from infants and the elderly is so common that physicians often needlessly prescribe broad-spectrum antibiotics prophylactically. Now, a team at The Hebrew University of Jerusalem's BioDesign: Medical Innovation program has developed an innovative microfiber pad that can save time and money in the collection of sterile samples.
The Plasma Protein Therapeutics Association (PPTA) applauds the introduction of bipartisan legislation, the Preserving Access to Orphan Drugs Act (H.R. 2672) and (S. 1423), which will safeguard the development of drugs and therapies that treat patients with rare diseases by eliminating barriers to innovation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Hale Vagts, MD 222 W 39th Ave, San Mateo, CA 94403-4364 Ph: () - | Dr Michael Hale Vagts, MD 222 W 39th Ave, San Mateo, CA 94403-4364 Ph: (650) 573-2530 |
News Archive
Sales increased by 14 percent during the fourth quarter and amounted to SEK 67 (59) million. Calculated in local currency growth was 15 percent. Sales for the year amounted to SEK 275 (225) million, corresponding to an increase of 22 percent. Calculated in local currencies growth was 10 percent.
Pioneering software that enables anesthetists to make better decisions for high risk patients during surgery has been awarded InnovateUK funding.
Contamination of urine samples from infants and the elderly is so common that physicians often needlessly prescribe broad-spectrum antibiotics prophylactically. Now, a team at The Hebrew University of Jerusalem's BioDesign: Medical Innovation program has developed an innovative microfiber pad that can save time and money in the collection of sterile samples.
The Plasma Protein Therapeutics Association (PPTA) applauds the introduction of bipartisan legislation, the Preserving Access to Orphan Drugs Act (H.R. 2672) and (S. 1423), which will safeguard the development of drugs and therapies that treat patients with rare diseases by eliminating barriers to innovation.
› Verified 6 days ago
Jennie Yoo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1950 Alameda De Las Pulgas, San Mateo, CA 94403 Phone: 650-570-3515 | |
Mariel Herbert, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 181 2nd Ave Ste 450, San Mateo, CA 94401 Phone: 415-922-9122 | |
Huaiyu Yang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 222 W 39th Ave, San Mateo, CA 94403 Phone: 650-573-2426 | |
Denise Albert, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 999 Baker Way Ste 420, San Mateo, CA 94404 Phone: 650-571-9652 Fax: 650-571-9657 | |
Darshana Sachin Pai, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 177 Bovet Rd Ste 300, San Mateo, CA 94402 Phone: 650-627-1700 | |
Ms. Ryuko Ishikawa, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 138 E Hillsdale Blvd, San Mateo, CA 94403 Phone: 415-640-1455 | |
Elizabeth J Rody, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1950 Alameda De Las Pulgas, San Mateo, CA 94403 Phone: 650-587-8574 |